0001973379-24-000032.txt : 20240214 0001973379-24-000032.hdr.sgml : 20240214 20240214114046 ACCESSION NUMBER: 0001973379-24-000032 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240214 DATE AS OF CHANGE: 20240214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Ascendis Pharma A/S CENTRAL INDEX KEY: 0001612042 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: G7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-36815 FILM NUMBER: 24634552 BUSINESS ADDRESS: STREET 1: TUBORG BOULEVARD 12 CITY: HELLERUP STATE: G7 ZIP: DK-2900 BUSINESS PHONE: 45 70 22 22 44 MAIL ADDRESS: STREET 1: TUBORG BOULEVARD 12 CITY: HELLERUP STATE: G7 ZIP: DK-2900 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: JENSEN MICHAEL WOLFF CENTRAL INDEX KEY: 0001965622 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O ASCENDIS PHARMA A/S STREET 2: TUBORG BOULEVARD 12 CITY: HELLERUP STATE: G7 ZIP: DK-2900 144 1 primary_doc.xml 144 0001965622 XXXXXXXX LIVE 0001612042 Ascendis Pharma A/S 001-36815 TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44 JENSEN MICHAEL WOLFF Officer EVP & Chief Legal Officer Common Stock Citigroup Global Markets Inc.

390 Greenwich Street New York NY 10013

931 134090.78 57707439 02/14/2024 NASDAQ Common Stock 02/14/2024 Restricted Stock Vesting Ascendis Pharma A/S N 931 02/14/2024 Services Rendered Y Under securities to be sold, the date acquired & date of payment are various dates. 02/14/2024 Conformed Signature on File